The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta-analysis

Cancer Medicine
Xi ZhongYongxi Song

Abstract

Patients with locally advanced rectal cancer (LARC) are at tremendous risk of metastatic diseases. To improve the prognoses of LARC patients, the efficacy of adding targeted agents to neoadjuvant therapy has been investigated by many researchers but remains controversial. A literature search of relevant databases was conducted through December 2016, 804 studies were identified and 32 investigations were ultimately included. A total of 1196 patients from 31 cohorts of 29 studies were eligible for quantitative synthesis in this single-arm setting meta-analysis. As pathologic complete response (pCR) shows promise as a prognosis indicator, we focused on pCR rates to evaluate whether adding targeted agents to neoadjuvant therapies improves the outcome of LARC patients. In our study, we revealed pooled estimates of pCR of 27% (95%CI, 21-34%) and 14% (95%CI, 9-21%) for bevacizumab-relevant cohorts and cetuximab-relevant cohorts, respectively. The safety of adding targeted agents to neoadjuvant therapy was also evaluated by pooling the data of Grade 3/4 toxicity. In conclusion, our study revealed that adding bevacizumab to the neoadjuvant therapy regimens provides appreciable pCR for LARC patients. Meanwhile, the efficacy of cetuximab ...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Aug 17, 2000·JAMA : the Journal of the American Medical Association·C CammàM Cottone
Apr 25, 2001·American Journal of Clinical Oncology·N A JanjanJ Skibber
Jun 14, 2002·International Journal of Radiation Oncology, Biology, Physics·Vincenzo ValentiniMaurizio Cosimelli
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Oct 22, 2004·The New England Journal of Medicine·Rolf SauerUNKNOWN German Rectal Cancer Study Group
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Fabio Maria VecchioClaudio Coco
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Jack Lee, Lei Feng
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-François BossetLaurence Collette
Aug 25, 2005·Journal of Surgical Oncology·Frank A ScappaticciHerbert Hurwitz
Oct 26, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claus RödelChristian Wittekind
Sep 15, 2006·The New England Journal of Medicine·Jean-François BossetUNKNOWN EORTC Radiotherapy Group Trial 22921
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GérardLaurent Bedenne
Jan 9, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-P MachielsK Haustermans
Sep 21, 2007·International Journal of Radiation Oncology, Biology, Physics·Claus RödelRolf Sauer
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurence ColletteUNKNOWN European Organisation for Research and Treatment of Cancer Radiation Oncology Group
Nov 16, 2007·The New England Journal of Medicine·Derek J JonkerMalcolm J Moore
Dec 20, 2007·American Journal of Clinical Oncology·Edgar Ben-Josef
Apr 15, 2008·International Journal of Radiation Oncology, Biology, Physics·Carlo CapirciGiuseppe La Torre
Jul 11, 2008·Journal of Surgical Oncology·Shouki BazarbashiDahish Ajarim
Jan 10, 2009·International Journal of Radiation Oncology, Biology, Physics·Karoline HorisbergerUNKNOWN MARGIT (Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren)
May 26, 2009·International Journal of Radiation Oncology, Biology, Physics·Christopher H CraneMiguel A Rodriguez-Bigas
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettRakesh K Jain
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine LiebigDaniel Albo
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Mar 27, 2010·International Journal of Radiation Oncology, Biology, Physics·Alexander K ChanDaryl A Jenken
Jun 30, 2010·International Journal of Radiation Oncology, Biology, Physics·Michael I KoukourakisEfthimios Sivridis
Oct 16, 2010·International Journal of Radiation Oncology, Biology, Physics·Tom DipetrilloHoward Safran
Feb 3, 2011·JAMA : the Journal of the American Medical Association·Vishal RanpuraShenhong Wu
May 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter P GrimmingerDaniel Vallböhmer
Jul 12, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Gudrun ReschUNKNOWN Austrian Breast and Colorectal Cancer Study Group

❮ Previous
Next ❯

Citations

Mar 29, 2020·Signal Transduction and Targeted Therapy·Yuan-Hong XieJing-Yuan Fang
Apr 17, 2020·Signal Transduction and Targeted Therapy·Yuan-Hong XieJing-Yuan Fang

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.